|
|
||||||||
IMMUNOLOGY, HEALTH, AND DISEASE |
Department of Poultry Science, University of Arkansas, Fayetteville 72701
1 Corresponding author: bhargis{at}uark.edu
| ABSTRACT |
|---|
|
|
|---|
Key Words: Salmonella probiotic lactic acid bacteria poultry
| INTRODUCTION |
|---|
|
|
|---|
The use of probiotics in poultry has been investigated since Rantala and Nurmi (1973) observed that exposure of young chicks to bacteria from the gut of mature birds conferred protection from infection. Selected beneficial bacteria such as lactic acid bacteria (LAB) have been proposed as probiotics for the prevention of various enteric diseases and the improvement of overall health for many years (Tellez et al., 2006). Previous probiotic cultures have successfully reduced enteric salmonellosis in poultry. Specifically, Baba and others (1991) found that using a combination of Escherichia coli and Lactobacillus spp. was more effective at reducing Salmonella Typhimurium colonization in chicks than treating with an individual probiotic isolate. An anaerobic probiotic culture comprised of 29 bacterial strains representing 10 genera also reduced the amount of recoverable Salmonella Typhimurium from chicks (Corrier et al., 1995, 1998). Other anaerobic cecal-extracted probiotic cultures have also proved effective at reducing Salmonella (Impey et al., 1984) or Salmonella and Campylobacter (Blankenship et al., 1993; Stern et al., 2001). These findings clearly demonstrate the ability of probiotic cultures to reduce Salmonella incidence in poultry.
The commercially available probiotic utilized in the present studies, consisting of 11 LAB isolates, has been shown to improve BW of turkeys experiencing idiopathic diarrhea under commercial conditions (Higgins et al., 2005b) and to increase performance of production turkeys under commercial conditions (Torres-Rodriguez et al., 2007). We evaluated the ability of this product to reduce the amount of recoverable Salmonella from the ceca of broiler chicks.
| MATERIALS AND METHODS |
|---|
|
|
|---|
A primary poultry isolate of Salmonella Enteritidis PT 13A or Salmonella Typhimurium, each resistant to novobiocin (NO, Catalog No. N-1628, Sigma, St. Louis, MO) and selected for resistance to nalidixic acid (NA, Catalog No. N-4382, Sigma), were used for these experiments. The amplification protocol has been described in detail (Higgins et al., 2005a). Briefly, Salmonella Enteritidis or Salmonella Typhimurium was incubated at 37°C for 24 h and passed every 8 h. Cells were then washed 3 times in sterile saline by centrifugation at 1,864 x g. Concentrations of Salmonella Enteritidis or Salmonella Typhimurium were retrospectively determined by spread plating on xylose lactose differential agar (XLD, Catalog No. 278820, Becton Dickinson, Sparks, MD) plates containing NO (25 µg/mL) and NA (20 µg/mL). Actual determined cfu for each experiment are reported in Table 1
.
|
Eleven LAB isolates, of poultry gastrointestinal origin, were previously selected and described (Higgins et al., 2005b). This commercial product (FM-B11, Catalog No. 41069, IVS-Wynco LLC, Springdale, AR) was diluted in reconstituted powdered skim milk to an expected concentration of 4 x 106 cfu/mL for oral gavage of chicks in these studies. Actual cfu administered per chick from each experiment are reported in Table 1
as determined retrospectively from spread plating on Mann Rogosa sharp agar (Catalog No. R1148, Sigma).
Experimental Design
For all experiments, day-of-hatch male broiler chicks were obtained from a local hatchery. Chicks used in all experiments were cared for using procedures approved by the University of Arkansas Institutional Animal Care and Use Committee. Chicks were randomly assigned to treatment groups and then challenged by oral gavage (0.25 mL) with Salmonella Enteritidis or Salmonella Typhimurium at approximately 104 cfu/chick (Table 1
) and placed into pens (n = 40 per pen). Heated brooder batteries were used for housing and chicks were allowed ad libitum access to unmedicated broiler starter ration and water for the duration of the experiment. One hour post Salmonella challenge, LAB was administered via oral gavage (0.25 mL) with vehicle administered to control groups. At selected times following LAB treatment (24-h experiments 1 to 3; 6, 12, and 24 h experiments 4 to 7), broilers were humanely killed by CO2 inhalation, and cecal tonsils and ceca were collected separately and aseptically (n = 25 per group in experiments 1 to 6; n = 20 per group in experiment 7). Cecal tonsils were enriched in 10 mL of tetrathionate broth overnight at 37°C. Following enrichment, each sample was streaked for isolation on XLD plates containing 25 µg/mL of NO and 20 µg/mL of NA. The plates were incubated at 37°C for 24 h and examined for the presence or absence of the antibiotic-resistant Salmonella Enteritidis or Salmonella Typhimurium. Ceca were homogenized within sterile sample bags (Catalog No. B00679WA, Nasco, Fort Atkinson, WI) using a rubber mallet. Sterile saline (3 mL) was added to each sample bag and hand stomached with the cecal contents. Dilutions were spread plated on XLD plates containing 25 µg/mL of NO and 20 µg/mL of NA. The plates were incubated at 37°C for 24 h, and cfu of Salmonella Enteritidis per cecal pair were determined.
Statistical Analysis
The incidence of Salmonella recovery within experiments was compared using the
2 test of independence (Zar, 1984) to determine significant (P < 0.05) differences between control and treated groups. Ceca cfu data were converted to log10 cfu numbers, then compared using the GLM procedure of SAS (SAS Institute, 2002) with significance reported at P < 0.05.
| RESULTS |
|---|
|
|
|---|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
In experiments 4 to 7 the incidence of Salmonella Enteritidis recovered from cecal tonsils of treated chicks was very similar to the untreated controls 6 and 12 h post-treatment. However, by 24 h a significant reduction associated with LAB treatment was observed. As observed at 24 h in experiments 1 to 3, significant treatment-associated reductions in numbers of Salmonella Enteritidis recovered from ceca were observed as early as 12 h posttreatment, whereas differences in incidence of recovery following enrichment were not observed until 24 h. These data suggest that the mechanism of pathogen reduction had been initiated within the first 12 h following treatment. The 2 most likely mechanisms by which this probiotic reduces the recovery of Salmonella involve bacterial interactions (competitive exclusion) or stimulation of a host innate immune response. Briefly, Mead (2000) proposed 4 methods by which competitive exclusion cultures are able to exclude enteric pathogens: competition for receptor sites, production of volatile fatty acids that are inhibitory of certain enteric pathogens, production of bactericins (antimicrobial peptides produced by 1 bacterium that inhibits another bacterium), or competition with pathogens and native flora for limiting nutrients. The LAB culture could reduce Salmonella recovery through a number of these inhibitory mechanisms. Additionally, because these lactic acid bacteria were isolated from mature poultry, their ability to survive in the gut of poultry is anticipated. Whereas bacterial interactions are the most accepted mechanism for this reduction of Salmonella, stimulation of an effective innate immune response could be more likely due to the rapidity of this response.
Stimulation of immune responses by probiotic cultures has been described in several animal models. Kim and coworkers (2006) demonstrated that parenteral administration of a probiotic Lactobacilli isolate increased expression of tumor necrosis factor-
, interleukin (IL)-12, IL-18, and interferon-
in the spleen of mice compared with vehicle-injected mice. Vinderola et al. (2004) also observed that oral administration of probiotics increased number of IgA-, tumore necrosis factor-
-, and IL-10-producing cells in the small intestine, whereas some reduced the number of IL-6 producing cells in the small and large intestine of mice following 5 d of treatment. Galdeano and Perdigon (2006) found that oral administration of Lactobacillus casei to mice did not significantly increase the number of CD3+, CD4+, CD8+, or IgA+ cells in the small intestine of mice within the first 5 d of treatment. However, there was a significant increase in the mannose binding CD-206 receptors in the small intestine 48 h following probiotic administration. The CD-206 receptor facilitates phagocytosis of mannosylated antigens and is expressed on antigen presenting cells such as dendritic cells and macrophages. This would indicate that the initial immune response is not T- or B-cell dependent, but rather dendritic cells or macrophages are responsible for the early innate immune response associated with probiotics. In poultry, Dalloul et al. (2003) described significantly higher levels of interferon-
and IL-2 in the intestine of probiotic-treated chickens 3 d following challenge with Eimeria acervulina. With all of these observations, it has still been difficult to determine the host responses that are most beneficial in the reduction of enteric pathogens. In the present studies, LAB treatment significantly reduced recovery of Salmonella. Further research will be conducted using this probiotic to determine the exact mechanism of pathogen reduction.
Received for publication December 16, 2006. Accepted for publication February 12, 2007.
| REFERENCES |
|---|
|
|
|---|
Bean, N. H., and P. M. Griffin. 1990. Food-borne disease outbreaks in the United States, 1973 1987: Pathogens and trends. J. Food Prot. 53:804. (Abstr.)[Web of Science]
Blankenship, L. C., J. S. Bailey, N. A. Cox, N. J. Stern, R. Brewer, and O. Williams. 1993. Two-step mucosal competitive exclusion flora treatment to diminish salmonellae in commercial broiler chickens. Poult. Sci. 72:16671672.[Web of Science][Medline]
Corrier, D. E., D. J. Nisbet, J. A. Byrd, B. M. Hargis, N. K. Keith, M. Peterson, and J. R. Deloach. 1998. Dosage titration of a characterized competitive exclusion culture to inhibit Salmonella colonization in broiler chickens during growout. J. Food Prot. 61:796801.[Web of Science][Medline]
Corrier, D., D. Nisbet, C. Scanlan, A. Hollister, and J. DeLoach. 1995. Control of Salmonella typhimurium in broiler chicks with a continuous-flow characterized mixed culture of cecal bacteria. Poult. Sci. 74:916924.[Web of Science][Medline]
Dalloul, R., H. Lillehoj, T. Shellem, and J. Doerr. 2003. Enhanced mucosal immunity against Eimeria acervulina in broilers fed a Lactobacillus-based probiotic. Poult. Sci. 82:6266.
FoodNet. 2005. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food10 sites, United States, 2004. Morb. Mortal. Wkly. Rep. 54:352356.[Medline]
Galdeano, C. M., and G. Perdigon. 2006. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 13:219226.
Hargis, B. M., D. J. Caldwell, and J. A. Byrd. 2001. Microbial pathogens of poultry: Live bird considerations. In Poultry Meat Processing. A. R. Sams, ed. CRC Press LLC, Boca Raton, FL.
Higgins, J., S. Higgins, K. Guenther, W. Huff, A. Donoghue, D. Donoghue, and B. Hargis. 2005a. Use of a specific bacteriophage treatment to reduce Salmonella in poultry products. Poult. Sci. 84:11411145.
Higgins, S., A. Torres-Rodriguez, J. Vicente, C. Sartor, C. Pixley, G. Nava, G. Tellez, J. Barton, and B. Hargis. 2005b. Evaluation of intervention strategies for idiopathic diarrhea in commercial turkey brooding houses. J. Appl. Poult. Res. 14:345348.
Impey, C., G. Mead, S. George, P. Wyeth, and N. Chettle. 1984. Attempt to control stunting in chickens by competitive exclusion. Vet. Rec. 115:3637.[Web of Science][Medline]
Kim, Y., T. Ohta, T. Takahashi, A. Kushiro, K. Nomoto, T. Yokokura, N. Okada, and H. Danbara. 2006. Probiotic Lactobacillus casei activates innate immunity via NF-
B and p38 MAP kinase signaling pathways. Microbes Infect. 8:9941005.[Web of Science][Medline]
Mead, G. C. 2000. Prospects for competitive exclusion treatment to control Salmonellas and other foodborne pathogens in poultry. Vet. J. 159:111123.[Web of Science][Medline]
Persson, U., and S. I. Jendteg. 1992. The economic impact of poultry-borne salmonellosis: How much should be spent on prophylaxis? Int. J. Food Microbiol. 15:207.
Rantala, M., and E. Nurmi. 1973. Prevention of the growth of Salmonella in chicks by the flora of the alimentary tract of chickens. Br. Poult. Sci. 14:627630.[Web of Science][Medline]
SAS Institute Inc. 20022003. Version 9.1. SAS, Cary, NC.
Stern, N., N. Cox, J. Bailey, M. Berrang, and M. Musgrove. 2001. Comparison of mucosal competitive exclusion and competitive exclusion to reduce Salmonella and Campylobacter spp. colonization in broiler chickens. Poult. Sci. 80:156160.
Tellez, G., S. E. Higgins, A. M. Donoghue, and B. M. Hargis. 2006. Digestive physiology and role of microorganisms. J. Appl. Poult. Res. 15:136144.
Torres-Rodriguez, A., A. M. Donoghue, D. J. Donoghue, J. T. Barton, G. Tellez, and B. M. Hargis. 2007. Performance and condemnation rates analysis of commercial turkey flocks treated with a Lactobacillus spp-based probiotic. Poult. Sci. 86:444446.
Vinderola, C. G., M. Medici, and G. Perdigon. 2004. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulation capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Microbiol. 96:230243.[Medline]
WHO. 2006. Subject: Drug resistant Salmonella. http://www.who.int/mediacentre/factsheets/fs139/en/ Accessed Nov. 2006.
Zar, J. 1984. Biostatistical Analysis. 2nd ed. Prentice-Hall, Englewood Cliffs, NJ.
This article has been cited by other articles:
![]() |
S. Vandeplas, R. D. Dauphin, C. Thiry, Y. Beckers, G. W. Welling, P. Thonart, and A. Thewis Efficiency of a Lactobacillus plantarum-xylanase combination on growth performances, microflora populations, and nutrient digestibilities of broilers infected with Salmonella Typhimurium Poult. Sci., August 1, 2009; 88(8): 1643 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Akbari, H. R. Haghighi, J. R. Chambers, J. Brisbin, L. R. Read, and S. Sharif Expression of Antimicrobial Peptides in Cecal Tonsils of Chickens Treated with Probiotics and Infected with Salmonella enterica Serovar Typhimurium Clin. Vaccine Immunol., November 1, 2008; 15(11): 1689 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Grimes, S. Rahimi, E. Oviedo, B. W. Sheldon, and F. B. O. Santos Effects of a Direct-Fed Microbial (Primalac) on Turkey Poult Performance and Susceptibility to Oral Salmonella Challenge Poult. Sci., July 1, 2008; 87(7): 1464 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Higgins, G. F. Erf, J. P. Higgins, S. N. Henderson, A. D. Wolfenden, G. Gaona-Ramirez, and B. M. Hargis Effect of Probiotic Treatment in Broiler Chicks on Intestinal Macrophage Numbers and Phagocytosis of Salmonella Enteritidis by Abdominal Exudate Cells Poult. Sci., November 1, 2007; 86(11): 2315 - 2321. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |